Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Melatonin: a popular hormone]

B Tarquini1, F Perfetto, R Tarquini

  • 1I Divisione di Medicinia Generale, Osperdale di Catterinara, Trieste.

Minerva Medica
|July 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.

Journal of internal medicine·2021
Same author

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus.

Orphanet journal of rare diseases·2020
Same author

Madelung disease : report of a case and review of the literature.

Acta chirurgica Belgica·2015
Same author

Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.

Journal of internal medicine·2014
Same author

Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.

Case reports in oncology·2014
Same author

Autoimmune hepatitis in a patient affected by neuromyelitis optica: a new association.

Clinics and research in hepatology and gastroenterology·2013
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
Same journal

Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

Minerva medica·2026
Same journal

Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

Minerva medica·2026
See all related articles

Melatonin (MEL), a pineal gland hormone, regulates circadian rhythms and has antioxidant properties. While MEL shows potential for age-related conditions and sleep disorders, further research is needed on long-term effects and product quality.

Area of Science:

  • Endocrinology
  • Chronobiology
  • Neuroscience

Background:

  • Melatonin (MEL) is a key hormone produced by the pineal gland.
  • MEL synchronizes the body's circadian systems with the light-dark cycle.
  • It also acts as an antioxidant, protecting against cellular damage.

Purpose of the Study:

  • To critically reassess the multifaceted roles and applications of melatonin.
  • To evaluate melatonin's potential in aging and age-associated diseases.
  • To review its established and potential therapeutic uses, particularly in sleep disorders.

Main Methods:

  • Literature review and critical analysis of existing studies on melatonin.
  • Examination of receptor-mediated and intracellular signaling functions.

Related Experiment Videos

  • Assessment of antioxidant capacity and effects on aging models.
  • Main Results:

    • Melatonin (MEL) plays a vital role in regulating circadian rhythms and possesses significant antioxidant capabilities.
    • Declining MEL production with age suggests potential benefits for age-related diseases, especially concerning the brain and immune system.
    • Its efficacy is well-established for specific sleep-wake rhythm disturbances.

    Conclusions:

    • Melatonin (MEL) has transitioned from a research hormone to a widely marketed product with diverse functions.
    • Further clinical studies are essential to ascertain the safety and efficacy of long-term MEL supplementation, particularly regarding potential side effects.
    • Concerns exist regarding the quality and purity of commercially available melatonin preparations.